Wang Xiaodong — SEC insider filings
SEC reporting owner CIK 1662982. 45 insider filings on record with FilingPulse; latest filed 2026-11-12.
Transaction summary — filings shown
Covers all 45 filings on record, filed 2020-08-12 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 207 legs across 29 filings — 622,131 shares, $159,151,893 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 56.
- Largest priced transaction: sale of 14,525 shares @ $366.58 ($5,324,550) in BeOne Medicines Ltd., filed 2026-09-30.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BeOne Medicines Ltd. (ONC) | Director | 45 | — | 207 legs · 622,131 sh · $159,151,893 | 56 |
Insider filings — Wang Xiaodong
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-12 | 4 | BeOne Medicines Ltd. (ONC) | Gift (G): 1,183 @ $0 | EDGAR |
| 2026-10-29 | 4 | BeOne Medicines Ltd. (ONC) | Option exercise (M): 31,028 @ $36.90 · Sale (S): 880 @ $355.56 · Sale (S): 1,440 @ $355.62 · Sale (S): 1,239 @ $357.54 · Sale (S): 1,681 @ $358.75 · Sale (S): 1,280 @ $359.72 · +7 more | EDGAR |
| 2026-10-15 | 4 | BeOne Medicines Ltd. (ONC) | Option exercise (M): 31,027 @ $36.90 · Sale (S): 7,167 @ $349.56 · Sale (S): 10,361 @ $350.47 · Sale (S): 5,681 @ $351.40 · Sale (S): 6,558 @ $352.57 · Sale (S): 1,260 @ $353.24 · +1 more | EDGAR |
| 2026-09-30 | 4 | BeOne Medicines Ltd. (ONC) | Option exercise (M): 31,028 @ $36.90 · Sale (S): 160 @ $356.97 · Sale (S): 120 @ $358.71 · Sale (S): 40 @ $359.16 · Sale (S): 2,241 @ $361.05 · Sale (S): 4,239 @ $362.17 · +6 more | EDGAR |
| 2026-09-10 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 1,181 @ $345.38 · Sale (S): 2,841 @ $346.16 · Sale (S): 1,517 @ $347.39 · Sale (S): 1,721 @ $348.01 · Option exercise (M): 31,027 @ $36.90 · Sale (S): 7,492 @ $348.31 · +4 more | EDGAR |
| 2026-06-15 | 4 | BeOne Medicines Ltd. (ONC) | Grant/award (A): 99,892 @ $0 · Grant/award (A): 193,492 (derivative) @ $0 | EDGAR |
| 2025-11-12 | 4 | BeOne Medicines Ltd. (ONC) | Gift (G): 424,073 @ $0 | EDGAR |
| 2025-09-11 | 4 | BeOne Medicines Ltd. (ONC) | Gift (G): 148,096 @ $0 | EDGAR |
| 2025-06-25 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 300 @ $263.50 · Sale (S): 1,100 @ $265.35 · Sale (S): 507 @ $266.57 · Sale (S): 100 @ $267.81 | EDGAR |
| 2025-06-12 | 4 | BeOne Medicines Ltd. (ONC) | Grant/award (A): 98,696 @ $0 · Option exercise (M): 41,760 @ $6.50 · Sale (S): 2,901 @ $261.20 · Sale (S): 15,878 @ $262.20 · Sale (S): 16,094 @ $263.17 · Sale (S): 6,787 @ $264.08 · +3 more | EDGAR |
| 2025-05-15 | 4 | BeiGene, Ltd. (BGNE) | Option exercise (M): 41,760 @ $6.50 · Sale (S): 10,221 @ $222.83 · Sale (S): 21,235 @ $223.41 · Sale (S): 10,104 @ $224.32 · Sale (S): 200 @ $225.68 · Option exercise (M): 542,880 (derivative) @ $0 | EDGAR |
| 2025-04-16 | 4 | BeiGene, Ltd. (BGNE) | Option exercise (M): 41,760 @ $6.50 · Sale (S): 995 @ $237.56 · Sale (S): 805 @ $238.48 · Sale (S): 2,884 @ $239.51 · Sale (S): 5,516 @ $240.41 · Sale (S): 2,229 @ $241.51 · +9 more | EDGAR |
| 2025-03-20 | 4 | BeiGene, Ltd. (BGNE) | Option exercise (M): 41,760 @ $6.50 · Sale (S): 2,417 @ $258.25 · Sale (S): 6,926 @ $259.08 · Sale (S): 2,694 @ $259.86 · Sale (S): 10,448 @ $261.44 · Sale (S): 11,245 @ $262.12 · +3 more | EDGAR |
| 2025-03-13 | 4 | BeiGene, Ltd. (BGNE) | Gift (G): 158,717 @ $0 | EDGAR |
| 2025-03-06 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 700 @ $251.70 · Sale (S): 2,000 @ $252.72 · Sale (S): 825 @ $253.55 · Sale (S): 1,275 @ $254.77 · Sale (S): 1,214 @ $255.71 · Sale (S): 1,809 @ $256.83 · +1 more | EDGAR |
| 2025-02-06 | 4 | BeiGene, Ltd. (BGNE) | Option exercise (M): 41,760 @ $6.50 · Sale (S): 9,099 @ $223.00 · Sale (S): 1,519 @ $224.18 · Sale (S): 2,161 @ $225.27 · Sale (S): 17,805 @ $226.35 · Sale (S): 9,776 @ $227.00 · +2 more | EDGAR |
| 2025-01-08 | 4 | BeiGene, Ltd. (BGNE) | Option exercise (M): 41,760 @ $6.50 · Sale (S): 19,251 @ $175.46 · Sale (S): 11,310 @ $176.67 · Sale (S): 4,260 @ $177.42 · Sale (S): 5,638 @ $178.39 · Sale (S): 1,301 @ $179.18 · +1 more | EDGAR |
| 2024-12-12 | 4 | BeiGene, Ltd. (BGNE) | Option exercise (M): 41,760 @ $6.50 · Sale (S): 2,600 @ $183.60 · Sale (S): 7,063 @ $184.83 · Sale (S): 9,956 @ $185.73 · Sale (S): 9,266 @ $186.99 · Sale (S): 6,350 @ $187.60 · +7 more | EDGAR |
| 2024-11-29 | 4 | BeiGene, Ltd. (BGNE) | Option exercise (M): 38,461 @ $6.50 · Sale (S): 4,425 @ $187.16 · Sale (S): 300 @ $187.61 · Sale (S): 5,875 @ $187.98 · Sale (S): 400 @ $188.55 · Sale (S): 2,700 @ $189.17 · +13 more | EDGAR |
| 2024-08-14 | 4 | BeiGene, Ltd. (BGNE) | Gift (G): 301,457 @ $0 | EDGAR |
| 2024-06-07 | 4 | BeiGene, Ltd. (BGNE) | Grant/award (A): 108,992 @ $0 · Grant/award (A): 410,657 (derivative) @ $0 | EDGAR |
| 2023-12-04 | 4 | BeiGene, Ltd. (BGNE) | Gift (G): 71,890 @ $0 · Other (J): 172,372 @ $0 | EDGAR |
| 2023-06-20 | 4 | BeiGene, Ltd. (BGNE) | Grant/award (A): 86,216 @ $0 · Grant/award (A): 327,249 (derivative) @ $0 | EDGAR |
| 2023-03-20 | 4 | BeiGene, Ltd. (BGNE) | Gift (G): 67,444 @ $0 | EDGAR |
| 2023-03-10 | 4 | BeiGene, Ltd. (BGNE) | Option exercise (M): 67,635 @ $0.13 · Sale (S): 3,433 @ $223.00 · Sale (S): 7,458 @ $224.01 · Sale (S): 12,534 @ $224.92 · Sale (S): 400 @ $225.35 · Sale (S): 200 @ $226.61 · +4 more | EDGAR |
| 2023-01-17 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 4,099 @ $260.31 · Sale (S): 901 @ $261.48 | EDGAR |
| 2023-01-11 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 900 @ $250 · Sale (S): 1,600 @ $250.09 · Sale (S): 200 @ $250.39 · Sale (S): 1,250 @ $252.22 · Sale (S): 950 @ $253.57 · Sale (S): 100 @ $254 | EDGAR |
| 2022-12-15 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 1,392 @ $210.59 · Sale (S): 956 @ $211.66 · Sale (S): 665 @ $212.38 | EDGAR |
| 2022-11-30 | 4 | BeiGene, Ltd. (BGNE) | Gift (G): 52,000 @ $0 | EDGAR |
| 2022-11-17 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 1,987 @ $210.14 | EDGAR |
| 2022-09-08 | 4 | BeiGene, Ltd. (BGNE) | Gift (G): 33,410 @ $0 | EDGAR |
| 2022-08-09 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 300 @ $186.69 · Sale (S): 200 @ $188.87 · Sale (S): 100 @ $190.19 · Sale (S): 100 @ $191.60 · Sale (S): 2,100 @ $193.70 · Sale (S): 600 @ $194.38 · +19 more | EDGAR |
| 2022-06-24 | 4 | BeiGene, Ltd. (BGNE) | Grant/award (A): 83,499 @ $0 · Grant/award (A): 471,913 (derivative) @ $0 | EDGAR |
| 2021-11-10 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 300 @ $342.71 · Sale (S): 200 @ $343.84 · Sale (S): 300 @ $344.96 · Sale (S): 775 @ $346.83 · Sale (S): 440 @ $348.03 · Sale (S): 662 @ $348.89 · +7 more | EDGAR |
| 2021-11-10 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 400 @ $343.10 · Sale (S): 100 @ $343.84 · Sale (S): 300 @ $344.96 · Sale (S): 700 @ $346.81 · Sale (S): 402 @ $347.71 · Sale (S): 700 @ $348.82 · +8 more | EDGAR |
| 2021-07-01 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 300 @ $342.68 · Sale (S): 437 @ $345.88 · Sale (S): 1,100 @ $347.31 · Sale (S): 1,500 @ $348.64 · Sale (S): 1,211 @ $349.89 · Sale (S): 300 @ $350.59 | EDGAR |
| 2021-06-21 | 4 | BeiGene, Ltd. (BGNE) | Grant/award (A): 39,000 @ $0 · Grant/award (A): 241,839 (derivative) @ $0 | EDGAR |
| 2021-05-12 | 4 | BeiGene, Ltd. (BGNE) | Option exercise (M): 44,109 @ $0.13 · Option exercise (M): 3,394 @ $0.13 · Sale (S): 1,100 @ $299.40 · Sale (S): 1,594 @ $300.20 · Sale (S): 311 @ $302.21 · Sale (S): 389 @ $303.10 · +1 more | EDGAR |
| 2020-12-17 | 4 | BeiGene, Ltd. (BGNE) | Gift (G): 165,295 @ $0 | EDGAR |
| 2020-12-14 | 4 | BeiGene, Ltd. (BGNE) | Gift (G): 88,010 @ $0 · Gift (G): 1,244,542 @ $0 · Gift (G): 1,244,542 @ $0 | EDGAR |
| 2020-10-20 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 5,000 @ $320 | EDGAR |
| 2020-10-07 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 5,000 @ $300 | EDGAR |
| 2020-09-29 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 4,380 @ $280.29 · Sale (S): 620 @ $281.34 | EDGAR |
| 2020-09-21 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 4,916 @ $260.26 · Sale (S): 84 @ $261.12 | EDGAR |
| 2020-08-12 | 4 | BeiGene, Ltd. (BGNE) | Gift (G): 1,560 @ $0 · Sale (S): 1,500 @ $208.91 · Sale (S): 1,194 @ $209.91 · Sale (S): 100 @ $210.59 · Sale (S): 400 @ $213.15 · Sale (S): 400 @ $214.83 · +1 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1662982 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs